|
ADAT3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.638200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.838800E-01 |
| Normal-vs-Stage2 |
4.789700E-02 |
| Normal-vs-Stage3 |
5.389600E-01 |
| Normal-vs-Stage4 |
2.363100E-03 |
| Stage1-vs-Stage2 |
1.328820E-01 |
| Stage1-vs-Stage3 |
9.399000E-01 |
| Stage1-vs-Stage4 |
1.575620E-02 |
| Stage2-vs-Stage3 |
2.411000E-01 |
| Stage2-vs-Stage4 |
1.746600E-01 |
| Stage3-vs-Stage4 |
8.063300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.952000E-01 |
| Normal-vs-AfricanAmerican |
9.212000E-02 |
| Normal-vs-Asian |
1.855040E-01 |
| Caucasian-vs-AfricanAmerican |
2.010200E-01 |
| Caucasian-vs-Asian |
3.764000E-01 |
| AfricanAmerican-vs-Asian |
6.571600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.217800E-01 |
| Normal-vs-Female |
1.965440E-01 |
| Male-vs-Female |
4.964200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.812000E-01 |
| Normal-vs-Extreme_Weight |
9.063400E-01 |
| Normal-vs-Obese |
3.521000E-01 |
| Normal-vs-Extreme_Obese |
5.725600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.245000E-01 |
| Normal_Weight-vs-Obese |
9.789600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.834600E-01 |
| Extreme_Weight-vs-Obese |
2.678400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.837200E-01 |
| Obese-vs-Extreme_Obese |
2.632800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.689400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.287630E-01 |
| Normal-vs-Age(61-80Yrs) |
6.112400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.173900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.060400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.652400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.213800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.625970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.999560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.304200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.805600E-01 |
| Normal-VS-Type2 PRCC |
2.232400E-02 |
| Normal-VS-KIRP CIMP |
6.200400E-03 |
| Normal-VS-Unclassified PRCC |
5.617200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.672170E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.809590E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.262000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.466630E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.585360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.871600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.331200E-01 |
| Normal-vs-N1 |
1.143600E-01 |
| Normal-vs-N2 |
6.238000E-02 |
| N0-vs-N1 |
2.011200E-01 |
| N0-vs-N2 |
1.614590E-01 |
| N1-vs-N2 |
4.890200E-01 |
|
|
